Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new published version of the study details page.SummaryDifference0.0%

- Check9 days agoChange DetectedThe Locations section updated the Bolzano entry: the region is now Trentino-Sudtirol (instead of Trentino-Alto Adige) and the listing reads Bolzano, Trentino-Sudtirol, Italy, 39100. This reflects a regional naming update and a more precise address for the site.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a new revision of the page metadata.SummaryDifference0.0%

- Check37 days agoChange DetectedNew study sites were added, including Taipei Veterans General Hospital (Site 1652), Taichung Veterans General Hospital (Site 1653), and China Medical University Hospital-Department of Urology (Site 1654), among others. The total number of locations is now listed as 209.SummaryDifference0.8%

- Check44 days agoChange DetectedRevision tag changed from v3.5.2 to v3.5.3. This update represents a revision history increment without modifying the information shown on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedLocation labels updated from Vienna to State of Vienna, with the address now shown as Vienna, State of Vienna, Austria, 1090 (replacing Vienna, Vienna, Austria, 1090); revision bumped from v3.5.0 to v3.5.2.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.